Hyper-IgG4 disease: report and characterisation of a new disease
2006

Understanding Hyper-IgG4 Disease

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Neild Guy H, Rodriguez-Justo Manuel, Wall Catherine, Connolly John O

Primary Institution: UCL Centre for Nephrology, Royal Free Hospital, London

Hypothesis

Is hyper-IgG4 disease a significant condition that can be diagnosed and treated effectively?

Conclusion

Hyper-IgG4 disease is an important condition to recognize, as the diagnosis can be readily verified and the outcome with treatment is very good.

Supporting Evidence

  • Histology from all 12 patients showed significant increases in IgG4-positive plasma cells compared with controls.
  • Patients with hyper-IgG4 disease often present with systemic symptoms and fever.
  • Treatment with glucocorticoids resulted in a rapid clinical response.

Takeaway

Hyper-IgG4 disease is a condition where the body has too many IgG4 antibodies, leading to inflammation and fibrosis. It can be treated effectively with steroids.

Methodology

The study involved histological examination of biopsy specimens from 12 patients diagnosed with idiopathic retroperitoneal fibrosis, looking for IgG4-expressing plasma cells.

Limitations

The study is based on a small sample size and may not represent all cases of hyper-IgG4 disease.

Participant Demographics

The participants included 12 patients with idiopathic retroperitoneal fibrosis, with a mix of ages and genders.

Digital Object Identifier (DOI)

10.1186/1741-7015-4-23

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication